While it’s difficult to receive a cancer diagnosis, the good news is that treatment options are growing. Immunotherapy is one of the latest cancer therapy innovations.
Find out More
Prevention4Me - Genetic Cancers Providence is helping women proactively manage their cancer risk by participating in the Prevention4Me program.
Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents
Early Diagnosis and Precision Genomics Help Reverse a Rare, Life-Threatening Cancer Complication
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
How ProvSeq biomarker testing helped change this patient’s cancer journey
The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths
According to the cdc, heart disease is the leading cause of death in America. Going all the way back to the 1950's. and while people have become familiar with genetic testing for cancer risk.
Findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems sho
Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale.
A research team from Renton, Wash based Providence has launched an interactive toolkit to help health systems boost equity in medical research.
A new Providence-led study published in Nature offers one of the most detailed looks yet at what actually happens inside the body after a pig kidney is transplanted into a human.
A Cross-Sectional Retrospective Case-Control Study on Predictors of Early Onset Colorectal Cancer in a Multi-State Community Health System.
Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible
New research recently published in the New England Journal of Medicine begs the question: Can an AI-based model revolutionize clinical research?
